218.99
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$218.44
Offen:
$220.13
24-Stunden-Volumen:
2.07M
Relative Volume:
0.18
Marktkapitalisierung:
$273.49B
Einnahmen:
$20.56B
Nettoeinkommen (Verlust:
$6.21B
KGV:
44.88
EPS:
4.8791
Netto-Cashflow:
$6.22B
1W Leistung:
+9.52%
1M Leistung:
+9.85%
6M Leistung:
+46.80%
1J Leistung:
+270.54%
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
219.01 | 272.78B | 20.56B | 6.21B | 6.22B | 4.8791 |
|
ASML
Asml Holding Nv
|
1,303.36 | 507.68B | 36.97B | 10.86B | 12.49B | 27.95 |
|
AMAT
Applied Materials Inc
|
349.69 | 276.55B | 28.21B | 7.84B | 6.19B | 9.7629 |
|
KLAC
Kla Corp
|
1,529.66 | 198.82B | 12.74B | 4.56B | 4.38B | 34.42 |
|
TER
Teradyne Inc
|
312.42 | 48.47B | 3.19B | 554.05M | 450.41M | 3.483 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Western Financial Corp CA Purchases New Stake in Lam Research Corporation $LRCX - MarketBeat
Whalen Wealth Management Inc. Makes New $1.42 Million Investment in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (FRA:LAR0) Stock Price, Trades & News - GuruFocus
Lam Research names new COO as part of leadership restructuring By Investing.com - Investing.com India
Lam Research Corp at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
Lam Research Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Lam Research Corp. Experiences Valuation Adjustment Amid Strong Financial Performance Metrics - Markets Mojo
Erste Group downgrades Lam Research stock rating to hold - Investing.com
Five Below and International Paper have been highlighted as Zacks Bull and Bear of the Day - The Globe and Mail
List of 8 Acquisitions by Lam Research (Apr 2026) - Tracxn
Kwmg LLC Has $13.10 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation Announces March Quarter Financial Conference Call - Sahm
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's Lam Research Corp(LRCX) Holding History - GuruFocus
Five Below and International Paper have been featured as Zacks' Bull and Bear of the Day selections - Bitget
Lam Research Corporation Announces March Quarter Financial Confe - GuruFocus
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research Corporation (LRCX): Billionaire Ray Dalio Trims Stake in Chip Stock - Insider Monkey
Why Lam Research (LRCX) is a Top Stock for the Long-Term - Yahoo Finance
KRS Capital Management LLC Purchases Shares of 14,475 Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by Nisa Investment Advisors LLC - MarketBeat
Allegro MicroSystems, Amkor, NXP Semiconductors, Photronics, and Lam Research Stocks Trade Up, What You Need To Know - Yahoo Finance
Lam Research Corp (LRCX) Shares Up 3.83% on Mar 31 - GuruFocus
IBM and Lam Research team up to advance sub-1nm chip technology - MSN
Lam Research Corp Stock (LRCX) Opened Up by 3.03% on Mar 31: What Investors Need To Know - TradingKey
Strong Demand Lifted Lam Research Corporation (LRCX) in Q4 - Yahoo Finance
LRCX Stock Price, Quote & Chart | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
Seagate, Applied Materials, KLA Corporation, Lam Research, and MACOM Stocks Trade Down, What You Need To Know - Yahoo! Finance Canada
Lam Research (NASDAQ:LRCX) Trading Down 5.4%Here's What Happened - MarketBeat
Micron Just Gave Incredible News to Investors of This AI Infrastructure Stock That Has Tripled in a Year - The Motley Fool
Lam Research Corp Stock (LRCX) Moved Down by 3.84% on Mar 30: Drivers Behind the Movement - TradingKey
What to Expect From Lam Research’s Next Quarterly Earnings Report - Barchart.com
LRCX Stock Quote Price and Forecast - CNN
Is Lam Research Corporation (LRCX) eyeing Besi Industries merger amid IBM pact for logic scaling - MSN
Lam Research Corporation (LRCX) partners with IBM - msn.com
AI-Driven Dynamics Propelled Lam Research (LRCX) Shares in Q4 - Yahoo Finance
Vanguard lists 0% stake in Lam Research (NASDAQ: LRCX) after realignment - Stock Titan
Lam Research Corp Stock (LRCX) Moved Down by 8.67% on Mar 27: Facts Behind the Movement - TradingKey
Assenagon Asset Management S.A. Reduces Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research (MEX:LRCX) NonCurrent Deferred Revenue : MXN0 Mil (As of Dec. 2025) - GuruFocus
Quantbot Technologies LP's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research Corp (LRCX) Stock Price Down 7.22% on Mar 26 - GuruFocus
Lam Research Corp Stock (LRCX) Opened Down by 3.98% on Mar 26: Facts Behind the Movement - TradingKey
Lam Research Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Lam Research Corporation (LRCX) is Positioned to Benefit from Growing Chip Complexity - Yahoo Finance
Outlier Inflows Push Lam Research Shares Higher - Yahoo Finance
Why the Market Dipped But Lam Research (LRCX) Gained Today - Yahoo Finance
Lam Research Corp Stock (LRCX) Moved Up by 5.32% on Mar 24: A Full Analysis - TradingKey
Jim Cramer on Lam Research: “You’ve Got a Winner in Lam Research” - Insider Monkey
Lam Research Corp (LRCX) Trading 3.1% Higher on Mar 23 - GuruFocus
Lam Research Corp Stock (LRCX) Moved Up by 3.09% on Mar 23: What Investors Need To Know - TradingKey
Lam Research Corporation (LRCX) Eyes $135 billion Opportunity - Insider Monkey
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bettinger Douglas R | Chief Financial Officer & EVP |
Mar 04 '26 |
Sale |
224.03 |
50,057 |
11,214,270 |
1,081,705 |
| Harter Ava | Chief Legal Officer |
Mar 04 '26 |
Sale |
222.66 |
1,500 |
333,990 |
53,205 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):